Derek D Satre1,2, Amy S Leibowitz3, Wendy Leyden3, Sheryl L Catz4, C Bradley Hare5, Hannah Jang3, Jennifer O Lam3, Kendall J Bryant6, Constance M Weisner7,3, Stacy A Sterling3, Michael Horberg8, Paul Volberding9, Michael J Silverberg3. 1. Department of Psychiatry, Weill Institute for Neurosciences, University of California, Box 0984, San Francisco, 401 Parnassus Avenue, San Francisco, CA, 94143, USA. derek.satre@ucsf.edu. 2. Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA, 94612, USA. derek.satre@ucsf.edu. 3. Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA, 94612, USA. 4. Betty Irene Moore School of Nursing, University of California, Davis, 2450 48th Street, Suite 2600, Sacramento, CA, 95817, USA. 5. Kaiser Permanente San Francisco Medical Center, 2238 Geary Blvd, San Francisco, CA, 94115, USA. 6. National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA. 7. Department of Psychiatry, Weill Institute for Neurosciences, University of California, Box 0984, San Francisco, 401 Parnassus Avenue, San Francisco, CA, 94143, USA. 8. Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States, 2101 East Jefferson, Rockville, MD, 20852, USA. 9. AIDS Research Institute, University of California, San Francisco, CA, 94158, USA.
Abstract
BACKGROUND: Unhealthy alcohol use has adverse effects on HIV treatment. Screening, brief intervention, and referral to treatment (SBIRT) has some evidence of efficacy but may not be sufficient for those with low motivation or comorbid substance use. OBJECTIVE: To examine the effectiveness of motivational interviewing (MI) and emailed feedback (EF) among primary care HIV-positive patients, compared with treatment as usual care (UC) only, which included SBIRT. DESIGN: Randomized clinical trial. PARTICIPANTS: Six hundred fourteen adult HIV-positive patients in Kaiser Permanente Northern California who reported prior-year unhealthy alcohol use. INTERVENTION: Participants were randomized to either three sessions of MI (one in person and two by phone), information regarding alcohol risks via EF through a patient portal, or UC alone. MI and EF participants who reported unhealthy alcohol use at 6 months were offered additional MI and EF treatment, respectively. MAIN MEASURES: Participant-reported unhealthy alcohol use (defined as ≥ 4/≥ 5 drinks per day for women/men), alcohol problems at 12 months, based on blinded telephone interviews. Secondary outcomes included drug use and antiretroviral (ART) adherence. KEY RESULTS: At 12 months, there were no overall group differences, but in all three arms, there were declines in unhealthy alcohol use and alcohol-related problems (p < 0.001). Participants reporting low motivation to reduce drinking at baseline were less likely to report unhealthy alcohol use if they received MI vs. EF and UC (p = 0.013). At 6 months, reported illegal drug use/misuse of prescription drugs other than marijuana was lower in the MI arm than EF or UC (p = 0.012). There were no differences in ART adherence between groups. CONCLUSIONS: In a randomized trial of HIV-positive patients using twobehavioral interventions compared with SBIRT alone, participants in all three conditions reduced unhealthy alcohol use. MI may provide added benefit for patients with low motivation or who report illegal drug use/misuse of prescription drugs. TRIAL REGISTRATION: NCT01671501 ( ClinicalTrials.gov ).
RCT Entities:
BACKGROUND: Unhealthy alcohol use has adverse effects on HIV treatment. Screening, brief intervention, and referral to treatment (SBIRT) has some evidence of efficacy but may not be sufficient for those with low motivation or comorbid substance use. OBJECTIVE: To examine the effectiveness of motivational interviewing (MI) and emailed feedback (EF) among primary care HIV-positivepatients, compared with treatment as usual care (UC) only, which included SBIRT. DESIGN: Randomized clinical trial. PARTICIPANTS: Six hundred fourteen adult HIV-positivepatients in Kaiser Permanente Northern California who reported prior-year unhealthy alcohol use. INTERVENTION: Participants were randomized to either three sessions of MI (one in person and two by phone), information regarding alcohol risks via EF through a patient portal, or UC alone. MI and EF participants who reported unhealthy alcohol use at 6 months were offered additional MI and EF treatment, respectively. MAIN MEASURES: Participant-reported unhealthy alcohol use (defined as ≥ 4/≥ 5 drinks per day for women/men), alcohol problems at 12 months, based on blinded telephone interviews. Secondary outcomes included drug use and antiretroviral (ART) adherence. KEY RESULTS: At 12 months, there were no overall group differences, but in all three arms, there were declines in unhealthy alcohol use and alcohol-related problems (p < 0.001). Participants reporting low motivation to reduce drinking at baseline were less likely to report unhealthy alcohol use if they received MI vs. EF and UC (p = 0.013). At 6 months, reported illegal drug use/misuse of prescription drugs other than marijuana was lower in the MI arm than EF or UC (p = 0.012). There were no differences in ART adherence between groups. CONCLUSIONS: In a randomized trial of HIV-positivepatients using two behavioral interventions compared with SBIRT alone, participants in all three conditions reduced unhealthy alcohol use. MI may provide added benefit for patients with low motivation or who report illegal drug use/misuse of prescription drugs. TRIAL REGISTRATION: NCT01671501 ( ClinicalTrials.gov ).
Entities:
Keywords:
HIV; SBIRT; adaptive intervention; alcohol; digital health; motivational interviewing; primary care
Authors: Richard Saitz; Tibor P A Palfai; Debbie M Cheng; Daniel P Alford; Judith A Bernstein; Christine A Lloyd-Travaglini; Seville M Meli; Christine E Chaisson; Jeffrey H Samet Journal: JAMA Date: 2014-08-06 Impact factor: 56.272
Authors: Daniel E Jonas; James C Garbutt; Halle R Amick; Janice M Brown; Kimberly A Brownley; Carol L Council; Anthony J Viera; Tania M Wilkins; Cody J Schwartz; Emily M Richmond; John Yeatts; Tammeka Swinson Evans; Sally D Wood; Russell P Harris Journal: Ann Intern Med Date: 2012-11-06 Impact factor: 25.391
Authors: Beverly B Green; Andrea J Cook; James D Ralston; Paul A Fishman; Sheryl L Catz; James Carlson; David Carrell; Lynda Tyll; Eric B Larson; Robert S Thompson Journal: JAMA Date: 2008-06-25 Impact factor: 56.272
Authors: Michael F Fleming; Stacey L Balousek; Paul M Grossberg; Marlon P Mundt; David Brown; Jennifer R Wiegel; Larissa I Zakletskaia; Elizabeth M Saewyc Journal: J Stud Alcohol Drugs Date: 2010-01 Impact factor: 2.582
Authors: Michael J Silverberg; Tory Levine-Hall; Nicole Hood; Alexandra N Anderson; Stacey E Alexeeff; Jennifer O Lam; Sally B Slome; Jason A Flamm; Charles Bradley Hare; Thekla Ross; Amy C Justice; Jonathan A C Sterne; Andrew E Williams; Kendall J Bryant; Constance M Weisner; Michael A Horberg; Stacy A Sterling; Derek D Satre Journal: Alcohol Clin Exp Res Date: 2020-11-10 Impact factor: 3.455
Authors: Derek D Satre; Alexandra N Anderson; Amy S Leibowitz; Tory Levine-Hall; Sally Slome; Jason Flamm; C Bradley Hare; Jennifer McNeely; Constance M Weisner; Michael A Horberg; Paul Volberding; Michael J Silverberg Journal: Contemp Clin Trials Date: 2019-08-22 Impact factor: 2.226
Authors: Michael Silverberg; Derek D Satre; J Carlo Hojilla; Julia Marcus; Jonathan E Volk; Wendy Leyden; C Bradley Hare; Rulin C Hechter; E Jennifer Edelman Journal: Sex Transm Infect Date: 2019-08-23 Impact factor: 3.519
Authors: Derek D Satre; Varada Sarovar; Wendy Leyden; Charles B Hare; Sheryl L Catz; Kendall J Bryant; Emily C Williams; J Carlo Hojilla; Michael A Horberg; Michael J Silverberg Journal: AIDS Behav Date: 2020-06
Authors: Thibaut Davy-Mendez; Varada Sarovar; Tory Levine-Hall; Alexandra N Lea; Stacy A Sterling; Felicia W Chi; Vanessa A Palzes; Kendall J Bryant; Constance M Weisner; Michael J Silverberg; Derek D Satre Journal: Drug Alcohol Depend Date: 2021-09-28 Impact factor: 4.492
Authors: Annie L Nguyen; Jordan E Lake; Diane Preciado; Diana Liao; Alison A Moore; Homero E Del Pino Journal: West J Nurs Res Date: 2020-04-02 Impact factor: 1.967
Authors: Michael J Silverberg; Derek D Satre; J Carlo Hojilla; Edda I Santiago-Rodriguez; Stacy Sterling; Emily C Williams; Wendy Leyden; C Bradley Hare Journal: AIDS Behav Date: 2021-01
Authors: Derek D Satre; Tory Levine-Hall; Stacy A Sterling; Kelly C Young-Wolff; Jennifer O Lam; Stacey Alexeeff; J Carlo Hojilla; Andrew Williams; Amy C Justice; Jonathan Sterne; Matthias Cavassini; Kendall J Bryant; Emily C Williams; Michael A Horberg; Paul Volberding; Constance Weisner; Michael J Silverberg Journal: Drug Alcohol Depend Date: 2021-01-08 Impact factor: 4.492
Authors: Erin E Bonar; Kelley M Kidwell; Amy S B Bohnert; Carrie A Bourque; Patrick M Carter; Sarah J Clark; Meyer D Glantz; Cheryl A King; Eve D Losman; Sean Esteban McCabe; Meredith L Philyaw-Kotov; Lisa A Prosser; Terri Voepel-Lewis; Kai Zheng; Maureen A Walton Journal: Contemp Clin Trials Date: 2021-08-02 Impact factor: 2.261
Authors: Michael D Stein; Debra S Herman; H Nina Kim; Abigail Howell; Audrey Lambert; Stephanie Madden; Ethan Moitra; Claire E Blevins; Bradley J Anderson; Lynn E Taylor; Megan M Pinkston Journal: AIDS Behav Date: 2020-10-12